The UCR-developed Tango mandarin has established itself as a symbol of innovation and sustainability in the global citrus ...
Founding CEO Barbara Weber, M.D. to become executive chair of the board of directorsMalte Peters, M.D., current board member, appointed President ...
Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
Biotech bank balances were again in focus Monday morning, with Tango Therapeutics cutting preclinical work to stretch its cash runway and Avalo Therapeutics outlining options for preserving its money.
Tango Therapeutics, Inc. remains a high-risk, high-reward biotech, focused on PRMT5 inhibitors for MTAP-deleted cancers—a large, underserved market opportunity. Disappointing clinical data last ...
Tango Therapeutics (NASDAQ:TNGX) added ~15% in the premarket on Thursday after the oncology-focused biotech announced an early-stage trial readout for its anticancer agent vopimetostat (TNG462) in ...
PRYME Audio Accessories has aligned with Tango Tango to provide seamless, hands-free push-to-talk over cellular solutions for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback